share_log

SINOVAC科兴EV71疫苗获得马来西亚GMP证书

The SINOVAC EV71 vaccine has obtained GMP certification in Malaysia.

Breakings ·  Mar 19 01:51

The inactivated vaccine for Enterovirus 71, Yierlaifu, produced by Beijing Sinovac Biotech Co., Ltd., a subsidiary of SINOVAC, has received GMP certification issued by the National Pharmaceutical Regulatory Agency (NPRA) of Malaysia. Malaysia is a member of the Pharmaceutical Inspection Co-operation Scheme (PIC/S), and obtaining GMP certification in Malaysia means that the production quality management system of Beijing Sinovac can be mutually recognized by PIC/S member countries, giving Yierlaifu the opportunity to be applied in a wider international market.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 367

Recommended

Write a comment

Statement

This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.